Clinical trial
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
NCT05940324 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
- Lead sponsor
- Stanford University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 24, 2024
- Completion date
- November 30, 2028
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.